InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
3
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+11.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by LOWE CHRISTOPHER P., COO et CFO. Insider active across 2 companies, notably Cortexyme, Inc.. Aggregated, 12 disclosures have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €166k. Activity tracked since 29 June 2021. The latest transaction was disclosed on 24 August 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
18,400 shares@ US$1.646718.3% of flowCommon StockSEC:0000899243-22-029840:0
Ideal exit: 21 May 2023 (T+270)
175,000 shares0Common StockSEC:0001209191-22-016440:0
30,000 shares@ US$2.237.9% of flowCommon StockSEC:0001209191-21-064924:0
30,000 shares@ US$2.237.9% of flowCommon StockSEC:0001209191-21-064924
4,963 shares@ US$54.8531.5% of flowCommon StockSEC:0001209191-21-059984:0
4,963 shares@ US$54.8531.5% of flowCommon StockSEC:0001209191-21-059984
22,000 shares@ US$2.235.6% of flowCommon StockSEC:0001209191-21-052277
22,000 shares@ US$2.235.6% of flowCommon StockSEC:0001209191-21-052277:0
20,000 shares@ US$2.235.0% of flowCommon StockSEC:0001209191-21-044027
6,400 shares@ US$12.5940.8% of flowCommon StockSEC:0000899243-21-026816
Ideal exit: 26 Mar 2022 (T+270)
6,400 shares@ US$12.590.71% mcap50.0% of flowCommon StockSEC:0000899243-21-026816:0
Ideal exit: 26 Mar 2022 (T+270)
20,000 shares@ US$2.235.0% of flowCommon StockSEC:0001209191-21-044027:0
12 of 12 declarations
About LOWE CHRISTOPHER P.
Christopher P. Lowe is the COO and CFO at Cortexyme, Inc. and Vincerx Pharma, Inc. He oversees operations and financial management for these companies.
